A 30 per cent hike in business has prompted MediaCom to strengthen
its management team through a series of promotions.
They include handing a board directorship to former Direct Line account
director Nigel Robinson and promoting five employees to associate
director level.
Robinson, 33, took over the pounds 30 million-plus Direct Line business
from director David Porter, who moved on to the Volkswagen account when
MediaCom won the brief at the end of last year.
Robinson oversees a team of four - including media manager Martin
Greenbank and planner Rachel Congdon - and also looks after the Sunday
Business account, worth pounds 5 million a year.
’Nigel came from the media business side of the agency and has been an
associate director for four years,’ said MediaCom’s Nick Lawson, who is
joint managing director of the agency, working alongside Jane
Ratcliffe.
Before he joined the agency, Robinson spent six years with Carat.
The new associate directors include director of radio Mike
Hope-Milne.
The former Classic FM group head and Western International Media head of
radio joined MediaCom in September last year.
Joining him as associate directors are Cathryn Crow and Adam Walsh from
MediaCom Direct. The direct marketing operation has been the fastest
growing division in the agency over the past two years and last week it
landed the pounds 2 million Digital Cellphones account.
The other two new associate directors are Estelle Friedman, head of the
pounds 35 million TV group, and Mick Mernagh, who is in charge of
qualitative research.
Lawson said the spate of promotions ’reflects the need to strengthen the
team’ after media billings grew to pounds 110 million last year.
No direct replacements are being sought for the employees who have
recently been promoted, but MediaCom’s growth has opened up 20 vacancies
at all levels within the company.
Lawson added that other internal and external appointments could be
expected ’in the near future’.
MediaCom’s client portfolio includes Direct Line, Procter & Gamble, IPC
Southbank, Mars, Roche Products and SmithKline Beecham.